期刊文献+

红霉素A9-(1-异丙氧基环己基)肟的合成及其晶体结构 被引量:6

Synthesis and Crystal Structure of Erythromycin A 9-(1-Iso-propoxycyclohexyl)oxime
在线阅读 下载PDF
导出
摘要 合成表征了红霉素A 9 ( 1 异丙氧基环己基 )肟的E和Z异构体 ,并在丙酮 -水混合溶剂中培养出了前者的单晶 .X射线衍射表明 ,其结构为正交晶系 ,P2 12 12 1空间群 ,晶胞参数 :a =2 .3 10 1( 5 )nm ,b =2 .3 761( 5 )nm ,c =0 .970 66( 19)nm ,V =5 .3 2 79( 18)nm3 ,Z =4,μ =0 .0 88mm-1,F( 0 0 0 ) =2 0 64 ,Dc=1.176g/cm3 .E 红霉素A 9 ( 1 异丙氧基环己基 )肟的晶体结构图明显表明 1 异丙氧基环己基保护基确实使十四元大环的构象发生了扭曲 ,使 6 OH的周围空间不再拥挤 ,从而导致 6 OH甲基化的选择性提高 . E- and Z-isomers of erythromycin A 9-(1-iso-propoxycyclohexyl)oxime have been synthesized and characterized. The crystal structure of E-isomer was determined by X-ray single-crystal structure analysis. The crystal belongs to orthorhombic system, P2(1)2(1)2(1) space group with a = 2.3101(5) nm, b 2.3761(5) m, c = 0.97066 (19) nm, V = 5.3279(18) nm(3), Z = 4, mu = 0.088 mm(-1), F(000) = 2064, D-c = 1.176 g/cm(3), R-1 = 0.0505, wR(2) = 0.0775 for 6747 unique reflections. The torsion angles of its fourteen-member erythrolide clearly elucidated the origin of regioselectivity occurring at 6-hydroxyl in the O-methylation of erythromycin A.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2003年第8期841-845,共5页 Chinese Journal of Organic Chemistry
基金 国家经贸委技术创新 (No.0 1BK 0 0 9)资助项目
关键词 红霉素 A9-(1-异丙氧基环己基)肟 合成 晶体结构 异构体 红霉素 醚化 克拉霉素 clarithromycin erythromycin etherification crystal isomer
  • 相关文献

参考文献16

  • 1石岩,钱国华,梁建华,姚国伟.红霉素肟合成反应研究[J].合成化学,2001,9(2):172-174. 被引量:11
  • 2孙京国,梁建华,邓志华,姚国伟.克拉霉素的合成进展[J].有机化学,2002,22(12):951-963. 被引量:29
  • 3Watanabe, Y.; Morimoto, S.; Omura, S. US 4331803, 1982[Chem. Abstr. 1982, 96, 142361d].
  • 4Morimoto, S. ; Nagate, T. ; Sugita, K. ; Ono, T. ; Numata, K. ;Miyachi, J.; Misawa, Y.; Yamada, K.; Omura, S. J.Antibiot. 1990, 43 (3), 295.
  • 5Agouridas, C.; Denis, A.; Auger, J. M.; Benedetti, Y.;Bonnefoy, A.; Bretin, F.; Chantot, J. F.;Dussarat, A.;Fromentin, C. ; Gouin D' Ambrires, S. ; Lachaud, S. ;Laurin,P. ;Le Martret, O. ; Loyau, V. ; Tessot, N. J. Med. Chem.1998, 41,4080.
  • 6Morimoto, S. ; Takahashi, Y. ; Watanabe, Y. ; Omura, S. J.Antibiot. 1984, 37(2), 187.
  • 7Morimoto, S. ; Adachi, T. ; Misawa, Y. ; Nagate, T. ;Watanabe, Y. ; Omura, S. J. Antibiot. 1990, 43(5), 544.
  • 8Watanabe, Y.; Morimoto, S.; Goi, M.; Mitsukuchi, M.;Adachi, T. ; Nakagami, J. ; Asaka, T. ; Eguchi, T. ;Sota, K.US 4672109, 1987 [Chem. Abstr. 1986, 104, 186804j].
  • 9Morimoto, S.; Adachi, T.; Matsunaga, T.; Kashimura, M.;Asaka, T.; Watanabe, Y.; Sota, K.; Sekiuchi, K. US4990602, 1991 [Chem. Abstr. 1990, 113, 132694r].
  • 10Omura, S. ; Morimoto, S. ; Nagate, T. ; Adachi, T. ; Kohno, Y.Yakugaku Zasshi 1992, 112(9), 593.

二级参考文献75

  • 1马舒冰.红霉素衍生物的半合成及构效关系[J].国外医药(抗生素分册),1996,17(1):33-37. 被引量:5
  • 2[1]McGuire J. M. ,Bunch et al.. Antiviot Chemother[J],1952,2:281-283.
  • 3[2]Wilkening,Robert R. ,Maplewood.. [P].8A-AZA-8A-Homoerythromycin Cyclic Imino Ethers. NJ US,5189159,1993.
  • 4[3]Jean-Claude Gasc,Solange Gouin D' Ambrieres,et al.. J Antibiotics[J],1991,44(3):313-330.
  • 5[4]Morimoto,Shigeo,Adachi,Takashi,Takahashi,Yoko,et al.. [P],Method for Preparing 6-O-methyl-2-O,N-bis(benzyloxycarbonyl) - N-demethytery thromycin A. EP, 0147062,1985.
  • 6[5]Amano T. ,Goi ,M.. Sekiuchi K.. [P] ,Process for Preparing Erythromycin a Oxime or a salt Therof. EP,0342990,1989.
  • 7[6]Jones,Richard A. Y.. Physical and Machanistic Organic Chemistry-2nd ed-Cambridge University Press[M]:London,1984.
  • 8Mcgurie, J. M.; Bunch, R. L.; Anderson, R. C.; Boaz,H. E.; Flynn, E. H.; Powell, H. M.; Smith, J. W. Antibiot. Chemother. 1952, 2, 281.
  • 9Kurath, P.; Jones, P. H.; Egan, R. S.; Perum, T. J.Experientia 1971, 27(4), 362.
  • 10Dutta, S. K.; Basu, S. K. US 4137397, 1979 [ Chem.Abstr. 1979, 90, 174677z].

共引文献37

同被引文献50

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部